Skip to Content

'
Paul M. Cinciripini, Ph.D.

Present Title & Affiliation

Primary Appointment

Professor w/Tenure, Department of Behavioral Science, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX
Director, Tobacco Treatment Program, Department of Behavioral Science, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Adjunct Professor, Department of Psychology, University of Houston, Houston, TX
Adjunct Professor, Department of Behavioral Science, UT School of Public Health, Houston, TX

Bio Statement

  

I serve as Professor and Deputy Chair for the Department of Behavioral Science, and am the Director of the Tobacco Treatment Program at MD Anderson Cancer Center. I have over 30 years experience conducting basic and clinical research in the area of smoking cessation and nicotine psychopharmacology. My major research interests includes studies developing novel behavioral and pharmacological treatments for nicotine dependence, and those that study individual differences associated with treatment outcome. In particular my work in this area has focused on psychological (negative affect, coping self-efficacy ), psychophysiological  (emotional reactivity), neural (EEG/fMRI) and genetic predictors of treatment outcome (pharmacogenetics). In addition to community based samples my work has also involved  populations with psychiatric and medical co-morbidities including depression, pregnancy and cancer. I have authored over 120 articles and book chapters, conducted over 18 NIH and other sponsored randomized clinical trials examining behavioral and pharmacological interventions for smoking cessation, and served as a senior co-investigator on over 20 NIH sponsored trials, and mentored 18 junior scientists. I am presently the PI or site PI on four active NIH funded studies.   I can make a major contribution to this study working with the PI as an senior co-investigator with the experience and infrastructure needed to conduct large scale clinical trials including those focusing on pregnant women and other special populations.

 

 

Research Interests

Paul M. Cinciripini, Ph.D. is Professor and Deputy Chair of the Department of Behavioral Science, and Director of the Tobacco Treatment Program, at the University of Texas MD Anderson Cancer Center. He has over 25 years experience conducting basic and clinical research in the area of smoking cessation and nicotine psychopharmacology.   Dr Cinciripini has been the recipient of several NIH, extramural and industry sponsored research grants and is the author of over 90 articles and book chapters. Dr. Cinciripini’s major research have include studies of nicotine titration and compensation, psychophysiological effects of nicotine during stress, individual differences in the effects of nicotine on EEG and cardiovascular activity, genetic factors treatment outcome, pharmacogenetic effects of antidepressants during smoking cessation, and recent studies using startle probe and EEG/ERP methodology to examine the relations between genetics, emotional reactivity, nicotine exposure and nicotine withdrawal. He has also studied the effects of depression, coping behavior and self-efficacy as well as genetic factors related to nicotine dependence and tested novel behavioral and pharmacological approaches for treatment. Examples of his work in this later area include: the development of a “scheduled smoking” procedure and a recent application of this technology for delivery on a handheld computer; development of a smoking cessation video series for pregnant smokers; evaluating combination therapies using nicotine replacement, behavioral counseling, and other approaches; and testing novel pharmacological compounds, including anxiolytics, antidepressants, nicotine partial agonists, and cannabinoid antagonists. He is presently the PI on three NIH funded clinical trials, including, “A Mood Management Intervention for Pregnant Smokers”, which evaluates a smoking cessation program for pregnant smokers based on a behavioral treatment for depression; “Pharmacogenetics, Emotional Reactivity and Smoking”; which designed to assess the effects of bupropion, varenicline and placebo on changes in emotional reactivity during cessation, as measured by the human startle response, EEG asymmetry and dense electrode recording of event related potentials (ERP), and to determine if these effects are moderated by genotype. He has also been awarded a competitive supplement to this grant to evaluate the pharmacogenetic response to emotional stimuli during cessation, using fMRI. The third project is a clinical trial evaluating the combined effects of Bupropion and Varenicline for smoking cessation. This study tests the hypothesis that the combined treatment will produce better cessation rates than the monotherapy (Varenicline alone) and will also result in lower levels of nicotine withdrawal and psychiatric side effects.

 

Education & Training

Degree-Granting Education

1978 Auburn University, Auburn, AL, PHD, Cum Laude, Clinical Psychology
1976 Auburn University, Auburn, AL, MS, Clinical Psychology
1974 Pennsylvania State University, State College, PA, BS, Psychology

Postgraduate Training

1977-1978 Clinical Residency, Clinical Psychology, Western Psychiatric Institute and Clinic, The University of Pittsburgh School of Medicine, Pittsburgh, PA

Board Certifications

1996 American Psychological Association Division 38
1993 American Board of Professional Psychology
1989 American Board of Behavioral Psychology
1983 Texas State Board of Examiners in Psychology

Experience/Service

Academic Appointments

Adjunct Professor, Department of Psychiatry, Baylor College of Medicine, Houston, TX, 10/2011-present
Associate Professor w/Tenure, Department of Behavioral Science, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 10/1994-9/2001
Associate Professor w/Tenure, Department of Psychiatry, University of Texas Medical Branch, Galveston, TX, 1988-1994
Assistant Professor, Department of Psychiatry, University of Texas Medical Branch, Galveston, TX, 1983-1988
Assistant Professor, Physiology, Minnesota School of Medicine, Duluth, MN, 1978-1983

Institutional Committee Activities

Chair, Search Committee: Section Chief of Behavioral Statistics, 2/2010-9/2012
Member, OVP Capital Equipment - Faculty Ranking Committee, 2/2009-present
Member, American Cancer Society Institutional Research Grant Review Committee, 1/2008-1/2011
Member, Department of Epidemiology Chair Search Committee, 2008-9/2010

Selected Publications

Peer-Reviewed Original Research Articles
1. Kendzor DE, Businelle MS, Costello TJ, Castro Y, Reitzel LR, Vidrine JI, Li Y, Mullen PD, Velasquez MM, Cinciripini PM, Cofta-Woerpel LM, Wetter DW. Breast feeding is associated with postpartum smoking abstinence among women who quit smoking due to pregnancy. Nicotine Tob Res 12(10):983-8, 10/2010. e-Pub 8/16/2010. PMCID: PMC2948049.
2. Versace F, Robinson JD, Lam CY, Minnix JA, Brown VL, Carter BL, Wetter DW, Cinciripini PM. Cigarette cues capture smokers' attention: Evidence from event-related potentials. Psychophysiology 47(3):435-441, 5/1/2010. e-Pub 1/11/2010. PMID: 20070579.
3. Smith SS, Piper ME, Bolt DM, Fiore MC, Wetter DW, Cinciripini PM, Baker TB. Development of the Brief Wisconsin Inventory of Smoking Dependence Motives. Nicotine Tob Res 12(5):489-99, 5/2010. e-Pub 3/15/2010. PMCID: PMC2861888.
4. Prokhorov AV, Kelder SH, Shegog R, Conroy JL, Murray N, Peters R, Cinciripini PM, De Moor C, Hudmon KS, Ford KH. Project ASPIRE: An interactive multimedia smoking prevention and cessation curriculum for culturally diverse high school students. Subst Use Misuse 45(6):983-1006, 5/2010. PMID: 20397881.
5. Reitzel LR, Vidrine JI, Businelle MS, Kendzor DE, Costello TJ, Li Y, Daza P, Mullen PD, Velasquez MM, Cinciripini PM, Cofta-Woerpel L, Wetter DW. Preventing Postpartum Smoking Relapse Among Diverse, Low Income Women: A Randomized Clinical Trial. Nicotine Tob Res 12(4):326-35, 4/2010. e-Pub 2/12/2010. PMCID: PMC2847071.
6. Carter BL, Paris MM, Lam CY, Robinson JD, Traylor AC, Waters AJ, Wetter DW, Cinciripini PM. Real-Time Craving Differences Between Black and White Smokers. Am J Addict 19(2):136-40, Mar-Apr, 3/2010. PMID: 20163385.
7. Kendzor DE, Businelle MS, Mazas CA, Cofta-Woerpel LM, Reitzel LR, Vidrine JI, Li Y, Costello TJ, Cinciripini PM, Ahluwalia JS, Wetter DW. Pathways between socioeconomic status and modifiable risk factors among African American smokers. Journal of Behavioral Medicine 32(6):545-557, 12/2009. e-Pub 9/2009. PMCID: PMC2828046.
8. Zevallos JP, Mallen MJ, Lam CY, Karam-Hage M, Blalock J, Wetter DW, Garden AS, Sturgis EM, Cinciripini PM. Complications of Radiotherapy in Laryngopharyngeal Cancer: Effects of a Prospective Smoking Cessation Program. Cancer 115(19):4336-4344, 10/1/2009. e-Pub 6/2009. PMID: 19569250.
9. Waters AJ, Reitzel LR, Cinciripini P, Li Y, Marcus MT, Vidrine JI, Wetter DW. Associations Between Mindfulness And Implicit Cognition and Self-Reported Affect. Substance Abuse 30(4):1-10, Oct-Dec, 10/2009. e-Pub 10/2009. PMID: 19904668.
10. Vidrine JI, Businelle MS, Cinciripini P, Li Y, Marcus MT, Waters AJ, Reitzel LR, Wetter DW. Associations of Mindfulness with Nicotine Dependence, Withdrawal, and Agency. Substance Abuse 30(4):318-327, Oct-Dec, 10/2009. PMID: 19904667.
11. Waters AJ, Carter BL, Robinson JD, Wetter DW, Lam CY, Kerst W, Cinciripini PM. Attentional Bias is Associated with Incentive-Related Physiological and Subjective Measures. Experimental & Clinical Psychopharmacology 17(4):247-57, 8/2009. PMID: 19653790.
12. Carter BL, Lam CY, Robinson JD, Paris MM, Waters AJ, Wetter DW, Cinciripini PM. Generalized craving, self-report of arousal, and cue reactivity after brief abstinence. Nicotine Tobacco Research 11(7):823-6, 7/2009. e-Pub 5/2009. PMCID: PMC2699928.
13. Businelle MS, Kendzor DE, Costello TJ, Cofta-Woerpel L, Li Y, Mazas CA, Vidrine JI, Reitzel LR, Cinciripini PM, Ahluwalia JS, Wetter DW. Light versus heavy smoking among African American men and women. Addictive Behaviors 34(2):197-203, 2/2009. e-Pub 10/2008. PMCID: PMC2614080.
14. Lam CY, Robinson JD, Carter BL, Wetter DW, Minnix JA, Cinciripini PM. Nicotine differentially inhibits the acoustic startle reflex in African American and Caucasian American smokers. Addictive Behaviors 33(12):1521-8, 12/2008. e-Pub 7/2008. PMCID: PMC2612003.
15. Kendzor DE, Costello TJ, Li Y, Vidrine JI, Mazas CA, Reitzel LR, Cinciripini PM, Cofta-Woerpel LM, Businelle MS, Wetter DW. Race/Ethnicity and Multiple Cancer Risk Factors among Individuals Seeking Smoking Cessation Treatment. Cancer Epidemiology Biomarkers Prevention 17(11):2937-45, 11/2008. PMID: 18990734.
16. Kendzor DE, Cofta-Woerpel LM, Mazas CA, Li Y, Vidrine JI, Reitzel LR, Costello TJ, Businelle MS, Ahluwalia JS, Cinciripini PM, Wetter DW. Socioeconomic status, negative affect, and modifiable cancer risk factors in African-American smokers. Cancer Epidemiology Biomarkers Prevention 17(10):2546-54, 10/2008. PMCID: PMC2602870.
17. Prokhorov AV, Kelder SH, Shegog R, Murray N, Peters R, Agurcia-Parker C, Cinciripini PM, de Moor C, Conroy JL, Hudmon KS, Ford KH, Marani S. Impact of A Smoking Prevention Interactive Experience (ASPIRE), an interactive, multimedia smoking prevention and cessation curriculum for culturally diverse high-school students. Nicotine & Tobacco Research 10(9):1477-1485, 9/2008. PMID: 19023839.
18. Carter BL, Lam CY, Robinson JD, Paris MM, Waters AJ, Wetter DW, Cinciripini PM. Real-time craving and mood assessments before and after smoking. Nicotine & Tobacco Research 10(7):1165-1169, 7/2008. NIHMSID: NIHMS248377.
19. Blalock JA, Robinson JD, Wetter DW, Schreindorfer LS, Cinciripini PM. Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment. Psychology of Addictive Behaviors 22(1):122-128, 3/2008. PMID: 18298238.
20. Blalock J, Fouladi R, Cinciripini P, Markowitz J, Klein D, Rothbaum B, Arnow B, Manber R, Riso L, Sui D, McCullough J, Jr. Cognitive and behavioral mediators of combined pharmacotherapy and psychotherapy of chronic depression. Cognitive Therapy and Research 32(2):197-211, 2008.
21. Waters AJ, Carter BL, Robinson JD, Wetter DW, Lam CY, Cinciripini PM. Implicit attitudes to smoking are associated with craving and dependence. Drug and Alcohol Dependence 91(2-3):178-86, 12/2007. e-Pub 7/2007. NIHMSID: NIHMSNIHMS33187.
22. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 110(7):1429-35, 10/1/2007. PMID: 17724670.
23. Rowan PJ, Cofta-Woerpel L, Mazas CA, Vidrine JI, Reitzel LR, Cinciripini PM, Wetter DW. Evaluating reactivity to ecological momentary assessment during smoking cessation. Exp Clin Psychopharmacol 15(4):382-389, 8/2007. PMID: 17696685.
24. Robinson JD, Cinciripini PM, Carter BL, Lam CY, Wetter DW. Facial EMG as an index of affective response to nicotine. Exp Clin Psychopharmacol 15(4):390-399, 8/2007. PMID: 17696686.
25. Robinson JD, Cinciripini PM, Tiffany ST, Carter BL, Lam CY, Wetter DW. Gender differences in affective response to acute nicotine administration and deprivation. Addict Behav 32(3):543-61, 3/2007. e-Pub 7/12/2006. PMID: 16842931.
26. Lam CY, Minnix JA, Robinson JD, Cinciripini PM. A brief review of pharmacotherapies for smoking cessation. J Natl Compr Canc Netw 4(6):583-9, 7/2006. PMID: 16813725.
27. Blalock JA, Robinson JD, Wetter DW, Cinciripini PM. Relationship of DSM-IV-based depressive disorders to smoking cessation and smoking reduction in pregnant smokers. Am J Addict 15(4):268-77, Jul-Aug, 7/2006. PMID: 16867921.
28. Carter BL, Robinson JD, Lam CY, Wetter DW, Tsan JY, Day SX, Cinciripini PM. A psychometric evaluation of cigarette stimuli used in a cue reactivity study. Nicotine Tob Res 8(3):361-9, 6/2006. PMID: 16801294.
29. Mazas CA, Cofta-Woerpel L, Daza P, Fouladi RT, Vidrine JI, Cinciripini PM, Gritz ER, Wetter DW. At-risk drinking in employed men and women. Ann Behav Med 31(3):279-87, 6/2006. PMID: 16700642.
30. Cinciripini PM, Robinson JD, Carter BL, Lam C, Wu X, de Moor CA, Baile WF, Wetter DW. The effects of smoking deprivation and nicotine administration on emotional reactivity. Nicotine Tob Res 8(3):379-92, 6/2006. PMID: 16801296.
31. Daza P, Cofta-Woerpel L, Mazas C, Fouladi RT, Cinciripini PM, Gritz ER, Wetter DW. Racial and Ethnic Differences in Predictors of Smoking Cessation. Subst Use Misuse 41(3):317-39, 2006. PMID: 16467009.
32. Robinson JD, Cinciripini PM. The effects of stress and smoking on catecholaminergic and cardiovascular response. Behav Med 32(1):13-8, 2006. PMID: 16637258.
33. Mallen M, Blalock J, Cinciripini P. Using technology to serve patients and practitioners: A comprehensive tobacco-cessation program for cancer patients. Counseling and Psychotherapy Research 6(3):196-201, 2006.
34. Prokhorov AV, Hudmon KS, Cinciripini PM, Marani S. Withdrawal Symptoms in Adolescents: A Comparison of Former Smokers and Never Smokers. Nicotine Tob Res 7(6):909-13, 12/2005. PMID: 16298726.
35. Cinciripini PM, Tsoh JY, Wetter DW, Lam C, de Moor C, Cinciripini L, Baile W, Anderson C, Minna JD. Combined effects of venlafaxine, nicotine replacement & brief counseling on smoking cessation. Exp Clin Psychopharmacol 13(4):282-292, 11/2005. PMID: 16366758.
36. Blalock JA, Fouladi RT, Wetter DW, Cinciripini PM. Depression in pregnant women seeking smoking cessation treatment. Addict Behav 30(6):1195-208, 7/2005. e-Pub 1/19/2005. PMID: 15925128.
37. Wetter DW, Cofta-Gunn L, Fouladi RT, Irvin JE, Daza P, Mazas C, Wright K, Cinciripini PM, Gritz ER. Understanding the associations among education, employment characteristics, and smoking. Addict Behav 30(5):905-14, 6/2005. PMID: 15893088.
38. Wetter DW, Cofta-Gunn L, Irvin JE, Fouladi RT, Wright K, Daza P, Mazas C, Cinciripini PM, Gritz ER. What accounts for the association of education and smoking cessation? Prev Med 40(5):452-60, 4/2005. PMID: 15530598.
39. Wetter DW, Cofta-Gunn L, Fouladi RT, Cinciripini PM, Sui D, Gritz ER. Late relapse/sustained abstinence among former smokers: a longitudinal study. Prev Med 39(6):1156-63, 12/2004. PMID: 15539050.
40. Skaar KL, Tsoh JY, McClure JB, Cinciripini PM, Friedman K, Wetter DW, Gritz ER. Smoking cessation. 1: An overview of research. Behavioral Medicine 23(1):5-13, 1997. PMID: 9201426.

Invited Articles
1. Karam-Hage M, Cinciripini PM. Pharmacotherapy for tobacco cessation: nicotine agonists, antagonists, and partial agonists. Curr Oncol Rep 9(6):509-16, 11/2007. PMID: 17991361.
2. Fingeret, M, Gritz E, Cinciripini P. State-of-the-Art Treatment for Smoking in Cancer Patients. The Texas Psychologist 58(1):18-20, 2007.

Abstracts
1. Rennard, S, Hughes, J, Cinciripini, PM, Kralikova, E, Raupach, T, Arteaga, C, St. Aubin, L, Russ, C. Randomized, placebo-controlled trial of varenicline for smoking cessation with flexible quit dates. 20th ERS Annual Congress, Barcelona, Spain, Sept 2010, 9/2010.
2. Cinciripini PM, Blalock JA, Minnix JA, Robinson JD, Brown VL, Lam CY, Wetter DW, Schreindorfer L. A Randomized Clinical Trial of an Intensive Depression-Focused Intervention for Smoking. Conference proceedings of the 2010 Society for Research on Nicotine and Tobacco Annual Meeting, Bethesda, MD. 2/2010.
3. Shiyko M, Ostroff J, Burkhalter J, Li Y, Cinciripini P, Holland S, Manna R. Adherence to Scheduled Reduced Smoking Intervention among Newly Diagnosed Cancer Patients. 30th Annual Meeting of the Society of Behavioral Medicine, 2/2010.
4. Versace F, Robinson JD, Lam CY, Minnix JA, Brown V, Cinciripini PM. Event Related Potentials to Cigarette-Related and Intrinsically Motivating Stimuli. 49th Annual Society for Psychophysiological Research Meeting; Berlin, Germany, 9/2009.
5. Vidrine JI, Businelle MS, Cinciripini PM, Li Y, Marcus M, Waters AJ, Reitzel LR, Wetter DW. Association of Mindfulness with Dependence, Withdrawal, and Agency Among Adult Smokers Preparing to Quit. 2009 Joint Conference of SRNT and SRNT-Europe, Dublin, Ireland, 4/2009.
6. Ostroff J, Burkhalter J, Li Y, Shiyko M, Cinciripini P, Lam C, Holland S, Manna R. Efficacy of a pre-surgical smoking cessation intervention for newly diagnosed cancer patients. [Abstract SYM3A]. 2009 Joint Conference of SRNT and SRNT-Europe, Dublin, Ireland, 4/2009.
7. Carter BL, Lam CY, Robinson JD, Paris MM, Traylor ACm Wetter DW, Cinciripini PM, Waters AJ. From the miserable to the happy-go-lucky; a cluster analysis of smokers' craving, mood and enjoyment assessed in real time. 2009 Joint Conference of SRNT and SRNT-Europe, Dublin, Ireland, 4/2009.
8. Wetter DW, Kendzor DE, Cofta Woerpel L, Irvin Vidrine JE, Costello TJ, Businelle M, Mazas CA, Reitzel LR, Li Y, Cinciripini PM. Modeling The Pathways Linking Socioeconomic Status And Smoking Relapse: A Structural Equation Modeling Approach. 2009 Joint Conference of SRNT and SRNT-Europe, Dublin, Ireland, 4/2009.
9. Burkhalter J, Ostroff J, Li Y, Shiyko M, Holland S, Cinciripini PM. Quitting self-efficacy moderates the impact of behavioral treatment in tobacco-dependent cancer patients. 2009 Joint Conference of SRNT and SRNT-Europe, Dublin, Ireland, 4/2009.
10. Ostroff J, Burkhalter J, Li Y, Shiyko M, Holland S, Cinciripini PM. Short-Term Effect of a Pre-Surgical Smoking Cessation Intervention for Newly Diagnosed Cancer Patients. 2009 Joint Conference of SRNT and SRNT-Europe, Dublin, Ireland, 4/2009.
11. Reitzel LR, Costello T, Irvin Vidrine JE, Li Y, Mullen PD, Velasquez MM, Cinciripini PM, Cofta Woerpel L, Greisinger A, Wetter DW. Subjective Social Status Is Associated With Postpartum Relapse. 2009 Joint Conference of SRNT and SRNT-Europe, Dublin, Ireland, 4/2009.
12. Paris MM, Carter BL, Lam CY, Robinson JD, Traylor AC, Waters AW, Wetter DW, Cinciripini PM. Who are these people? The mystery of non-responders. 2009 Joint Conference of SRNT and SRNT-Europe, Dublin, Ireland, 4/2009.
13. Blalock JA, Robinson JD, Cinciripini PM, Karam-Hage M, Brown RA, Mccullough JP. Nicotine Withdrawal in Chronically Depressed Smokers Undergoing Intensive Smoking Cessation Treatment. 14th World Conference on Tobacco OR Health Conference, Mumbai, India, 3/12/09, 3/2009.
14. LaConte SM, King-Casas B, Eagleman DM, Cinciripini PM, Versace F, Chiu PH. Modulating real-time fMRI neurofeedback interfaces via craving and control in chronic smokers. Human Brain Mapping. e-Pub 2009.
15. Miller LA, Karam-Hage M, Lal LS, Mallen M, Feng C, Blalock J, Cinciripini PM. Economic Evaluation of a Tobacco Cessation Program at a Major Cancer Center. ISPOR 11th Annual European Conference; Athens, Greece, 11/2008.
16. Versace F, Robinson JD, Minnix JA, Lam CY, Carter BL, Wetter DW, Cinciripini PM. Startle Probe P3 Amplitude When Viewing Cigarette Cues. 48th Annual Meeting of the Society for Psychophysiological Research; Austin, TX. 10/2008.
17. Versace F, Robinson JD, Minnix JA, Lam CY, Carter BL, Wetter DW, Cinciripini PM. Startle Probe P3 Amplitude When Viewing Cigarette Cues. 10th Annual Conference of SRNT Europe; Rome, Italy. 9/2008.
18. Mallen MJ, Karam-Hage M, Blalock JA, Cinciripini PM. A Comprehensive Tobacco-Cessation Treatment for Cancer Patients: Preliminary Outcome Findings. 14th Annual meeting of the Society for Research on Nicotine and Tobacco, Portland OR, 2/2008.
19. Karam-Hage M, Mallen MJ, Heater ML, Blalock JA, Cinciripini PM. Does Combining Bupropion-SR and Varenicline Make a Difference? A Preliminary Efficacy Report in Cancer Patients. 14th Annual meeting of the Society for Research on Nicotine and Tobacco, Portland OR, 2/2008.
20. Blalock JA, Karam-Hage M, Mallen MJ, Cinciripini PM. Prevalence of Psychiatric Disorders in Cancer Patients Receiving Tobacco-Cessation Treatment. 14th Annual meeting of the Society for Research on Nicotine and Tobacco, Portland OR, 2/2008.
21. Carter BL, Lam CY, Robinson, JD, Wetter DW, Cinciripini PM. Smoking cue responses decay after two weeks of abstinence. 14th Annual meeting of the Society for Research on Nicotine and Tobacco, Portland, OR, 2/2008.
22. Mallen MJ, Zevallos JP. Lam CY, Karam-Hage M, Blalock JA, Wetter DW, Garden AS, Sturgis EM, Cinciripini PM. Smoking and Recurrent Disease in a Head and Neck Cancer Population Receiving Radiotherapy. 14th Annual meeting of the Society for Research on Nicotine and Tobacco, Portland OR, 1/2008.
23. Heater ML, Karam M, Mallen M, Evans M, Blalock J, Cinciripini P. Development of a clinical treatment pathway for a unique tobacco cessation program within a comprehensive cancer center. Oncology Nursing Society 2007 APN Conference, Chicago, IL, 11/2007.
24. Waters A, Carter B, Robinson J, Lam C, Wetter D, Cinciripini P. Attention To Smoking Cues Is Associated with Incentive-Related Physiological and Subjective Measures. Society for Research on Nicotine and Tobacco - Europe, Madrid, Spain, 10/2007.
25. Reitzel LR, Vidrine JI, Li Y, Mullen PD, Velasquez MM, Cinciripini PM, Cofta-Woerpel L, Greisinger A, Wetter DW. The Influence of Subjective Social Status on Vulnerability to Postpartum Smoking Among Young Pregnant Women. Am J Public Health 97(8):1476-82, 8/2007. e-Pub 6/2007. PMCID: PMC1931465.
26. Waters A, Carter B, Robinson J, Wetter D, Cinciripini P. Implicit Attitudes to Smoking Cues Are Associated with Craving and Dependence. Society for Research on Nicotine and Tobacco, 2007.
27. Nayak N, Blalock J, Wetter D, Cinciripini P. Predictors of attendance and compliance in pregnant smokers seeking cessation treatment. Association for Behavioral and Cognitive Therapies. Philadelphia, PA, 2007.
28. Mallen M, Devine D, Blalock J, Smith T, Wetter D, Cinciripini P. Comprehensive Tobacco-Cessation Treatment for Cancer Patients: The Challenge of Implementing the Clinical Practice Guideline. Society for Research on Nicotine and Tobacco. Orlando, FL, 2006.
29. Cinciripini P, Lam C, Blalock J, Robinson J, Wetter D, Baile W. Does Scheduled Reduced Smoking Have a Place Among Smoking Cessation Treatments. Society for Research on Nicotine and Tobacco. Orlando, FL, 2006.
30. Hughes J, Cinciripini P, Peters E, Shiffman S. New Data on Gradual Cessation Treatments. Society for Research on Nicotine and Tobacco. Orlando, FL, 2006.
31. Wetter D, Cinciripini P. Palmtop Computer-Delivered Treatments for Smoking Cessation. Society for Research on Nicotine and Tobacco. Orlando, FL, 2006.
32. Cinciripini P, Aubin H-J, Dale L, Niaura R, Anthenelli R, the Stratus Group. Pooled analysis of three short-term, randomised, double-blind, placebo controlled trials with rimonabant 20 mg/d in smoking cessation. Society for Research on Nicotine and Tobacco Europe, Kusadasi/Ephesus, Turkey, 2006.
33. Lam C, Cinciripini P. Remembering the worst and the last moments: A Peak-End analysis of momentary and retrospective assessments of negative affect in smokers. 5th Annual Conference of the International Society for the Prevention of Tobacco Induced Disease, Hong Kong SAR, China, 2006.
34. Robinson J, Lam C, Minnix J, Wetter D, Cinciripini P. The DRD2 Taq1-B Polymorphism and Its Relationship to Smoking Abstinence. Society for Research on Nicotine and Tobacco. Orlando, FL, 2006.
35. Minnix J, Robinson J, Lam C, Carter B, Wetter D, Cinciripini P. The serotonin transporter gene and affective processing of emotional cues during nicotine deprivation. Society for Research on Nicotine and Tobacco. Orlando, FL, 2006.
36. Blalock J, Mallen M, Cinciripini P. Treatment of tobacco dependence in head and neck cancer patients: M.D. Anderson Cancer Center Tobacco Treatment Program. The American Head & Neck Society. Chicago, IL, 2006.

Book Chapters
1. Karam-Hage M. Minnix JA, Cinciripini PM. Nicotine: Clinical Aspects of Alcohol and Drug Addiction. In: Addictive Disorders and Substance Abuse. Ed(s) BA Johnson. Springer Publishers: New York, NY, 417-443, 2010.
2. Carter B, Cinciripini P, Wetter D, Day S. Momentary Health Interventions:Where are We and Where are We Going? In: The Science of Real-Time Data Capture: Self-Reports in Health Research. Ed(s) Stone, A.A., Shiffman, S., Atienza, A.A. & Nebeling, L. (Eds.). Oxford University Press: New York, 289-307, 2007.

Grant & Contract Support

Title: Smoking, Emotional Reactivity and Stress, TBD
Funding Source: NIH/NCI
Role: Principal Investigator
Duration:
 
Title: Identifying topiramates therapeutic mechanisms through motivational salience, TBD
Funding Source: NIH
Role: Co-Investigator
Principal Investigator: Jason Robinson
Duration: 9/1/2012 - 8/31/2017
 
Title: Beyond Cue Reactivity: ERPs, Sensitivity to Natural Rewards and Smoking Cessation, TBD
Funding Source: NIH/NCI
Role: Co-Principal Investigator
Principal Investigator: Francesco Versace
Duration: 7/15/2012 - 6/30/2015
 
Title: Identifying neurocognitive risk markers that differentiate smokers from never-smokers and ex-smokers, TBD
Funding Source: Duncan Family Institute
Role: Co-Investigator
Principal Investigator: Jason Robinson
Duration: 8/1/2011 - 7/31/2013
 
Title: A Phase 4, randomized, double-blind, active and placebo-controlled, multicenter study evaluating the neuropsychiatric safety and efficacy of 12 weeks varenicline tartrate 1mg BID for smoking cessation in subjects with and without a history of psychiatric, TBD
Funding Source: Pfizer Inc.
Role: Principal Investigator
Duration: 8/1/2011 - 7/31/2013
 
Title: Subcontract: Pharmacogenetics of nicotine addiction treatment., TBD
Funding Source: NIH/NCI
Role: Principal Investigator-MDACC
Principal Investigator: Lerman, Caryn (PI) (Cinciripini, Site PI)
Duration: 8/1/2010 - 6/30/2015
 
Title: New pharmacotherapy for alcohol and co-morbid disorders, TBD
Funding Source: NIH/NIDA
Role: Co-Principal Investigator
Principal Investigator: Cinciripini, P., Alt-Daoud, N., Anthenelli, R.
Duration: 7/1/2010 - 6/30/2015
 
Title: Effects from Nicotinic Receptor Variations on Smoking Behaviors and Lung Cancer Risk, TBD
Funding Source: Cancer Prevention Research Institute of Texas
Role: Co-Investigator
Principal Investigator: Krahe
Duration: 3/1/2010 - 2/28/2013
 
Title: Preliminary Effectiveness and Safety of Bupropion to Promote Smoking Cessation During Pregnancy, TBD
Funding Source: UTHealth The University of Texas Health Science Center
Role: Principal Investigator-MDACC
Principal Investigator: Stotts, Angela
Duration: 9/1/2009 - 8/31/2011
 
Title: Intensive smoking cessation intervention for head and neck cancer patients., TBD
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Blalcok
Duration: 8/1/2009 - 7/31/2013
 
Title: Error Sensitivity as a Predictor of Nicotine Withdrawal & Smoking Cessation, TBD
Funding Source: NIH/NIDA
Role: Co-Principal Investigator
Duration: 8/1/2009 - 7/31/2013
 
Title: Suppression of Negative Affect Indexed by the Late Positive Potential in Smokers, TBD
Funding Source: NIH/NIDA
Role: Co-Investigator
Principal Investigator: Minnix, Jennifer
Duration: 5/1/2009 - 4/30/2014
 
Title: Using ecological momentary assessment to examine pain and smoking in head and neck cancer patients, TBD
Funding Source: NIH/NCI
Role: Mentor
Principal Investigator: Lam
Duration: 4/30/2009 - 3/31/2012
 
Title: Effectiveness of Varenicline plus Bupropion for Smoking Cessation, TBD
Funding Source: NIH/NIDA
Role: Principal Investigator
Duration: 4/1/2009 - 12/31/2014
 
Title: Combating Tobacco in the United States Army , TBD
Funding Source: Department of Defense (DOD)
Role: Co-Investigator
Principal Investigator: Prokhorov
Duration: 4/1/2009 - 3/31/2013
 
Title: Ecological Momentary Assessment, Peak-end Rule, and Smoking Relapse., TBD
Funding Source: American Cancer Society (ACS)
Role: Mentor
Principal Investigator: Lam, Cho
Duration: 1/1/2009 - 12/31/2014
 
Title: Subcontract to: Localized and distributed real-time fMRI approaches to facilitate self control in substance abusers, TBD
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Chiu. Pearl
Duration: 9/1/2008 - 8/31/2013
 
Title: The Effects of Smoking and Expectancy on ERP measures of attentional bias, TBD
Funding Source: NIH/NIDA
Role: Mentor,
Principal Investigator: Robinson
Duration: 8/1/2008 - 5/30/2013
 
Title: Pharmacogenetics, emotional reactivity and smoking cessation: Genetic differences in limbic activation associated with nicotine withdrawal (competitive supplement), TBD
Funding Source: NIH/NIDA
Role: Principal Investigator
Duration: 5/1/2008 - 4/30/2012
 
Title: Smoking Cessation Intervention for Depressed Smokers: Treatment Development-Supplement, TBD
Funding Source: NIH/NIMH
Role: Co-Investigator
Principal Investigator: Blalock
Duration: 9/12/2006 - 7/31/2011
 
Title: An Innovative telephone intervention for HIV+ smokers, TBD
Funding Source: NIH/NIMH
Role: Co-Investigator
Principal Investigator: Gritz
Duration: 2/1/2006 - 12/31/2010
 
Title: Sub-Contract to: Cognitive processes in smoking cessation, TBD
Funding Source: NIH/NIDA
Role: Principal Investigator-MDACC
Principal Investigator: Waters
Duration: 9/30/2005 - 8/31/2010
 
Title: Group Therapy for Nicotine Dependence, TBD
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Wetter D
Duration: 9/30/2004 - 8/31/2010
 
Title: Pharmacogenetics, emotional reactivity and smoking, TBD
Funding Source: NIH/NIDA
Role: Principal Investigator
Duration: 7/15/2004 - 4/30/2012
 
Title: Project Export, A Center Of Excellence (Peace) (PI-2 Wetter), TBD
Funding Source: National Center On Minority Health And Health Disparities
Role: Co-Investigator
Principal Investigator: Jones, Lovell
Duration: 9/30/2003 - 4/30/2012
 
Title: A mood management intervention for pregnant smokers, TBD
Funding Source: NIH/NIDA
Role: Principal Investigator
Duration: 8/1/2003 - 4/30/2010
 
Title: Race/Ethnicity and the process of smoking cessation, TBD
Funding Source: NIH/NIDA
Role: Co-Investigator
Principal Investigator: Wetter
Duration: 9/30/2001 - 8/31/2007
 
Title: Treatment of Nicotine Dependence Among African Americans, TBD
Funding Source: NIH/NCI
Role: Co-Investigator
Duration: 9/30/2001 - 8/31/2006
 
Title: Curbing tobacco use in rural and suburban schools, TBD
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Prokhorov
Duration: 7/9/2000 - 6/30/2011
 
Title: Genetic Factors in the modulation of mood by nicotine, TBD
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 9/1/1999 - 8/31/2004
 
Title: Subcontract to: Computational Substrates of Addiction and Reward, TBD
Funding Source: NIH/NIDA
Role: Co-Investigator
Principal Investigator: Montague, P Read
Duration: 4/1/1998 - 2/28/2014
 
Title: Genetics mood and nicotine withdrawal, TBD
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 9/1/1997 - 8/31/2003

Last updated: 3/12/2013